The Infinity War: How to Cope with Carbapenem-resistant Enterobacteriaceae
Journal of Korean Medical Science
;
: e255-2018.
Article
in English
| WPRIM
| ID: wpr-717696
ABSTRACT
Carbapenem-resistant Enterobacteriaceae (CRE) are now spread worldwide. In Korea, the number of CRE isolation is rapidly increasing, and impending endemicity is a concern. To cope well with CRE, thorough infection control, such as active surveillance, early detection, strict contact precaution, cleaning the environment, and antibiotic stewardship is very important. Therapeutic options include polymyxin, tigecycline, fosfomycin or the combination of them with carbapenem, which is currently the mainstay of treatment. In addition, various combination regimens with new carbapenemase inhibitors such as avibactam, vaborbactam, or relebactam, and other classes of antimicrobials such as plazomicin and siderophore cephalosporin are in the process of evaluation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Carbapenems
/
Infection Control
/
Polymyxins
/
Enterobacteriaceae
/
Fosfomycin
/
Korea
Type of study:
Screening study
Country/Region as subject:
Asia
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS